净利增长70%！大博医疗2025年业绩预告

Core Viewpoint - The understanding of "growth" in the orthopedic high-value consumables industry is shifting towards maintaining profit and cash flow under continuous price pressure, rather than just revenue expansion [2]. Group 1: Performance Forecast - Dabo Medical expects a net profit attributable to shareholders of 580-610 million yuan for 2025, representing a year-on-year growth of 62.55%-70.96% [2][3]. - The net profit after deducting non-recurring gains and losses is projected to be 455-485 million yuan, with a year-on-year increase of 59.42%-69.93% [2][3]. - The basic earnings per share are estimated to be between 1.43 and 1.50 yuan, compared to 0.86 yuan in the previous year [3]. Group 2: Consistent Performance - The performance in 2025 is not a result of year-end rush but rather a gradual realization throughout the year [4][6]. - In the first three quarters, the company achieved a net profit of 425 million yuan, a year-on-year increase of 77.03%, laying a solid foundation for the annual performance forecast [4]. Group 3: Profit Growth vs. Revenue Growth - The company's revenue growth of 22.69% in the first three quarters is not particularly outstanding, but profit growth significantly outpaces revenue growth [7][8]. - The increase in operating profit and net profit attributable to shareholders is notably higher than revenue growth, indicating improved operational efficiency and cost control [8]. Group 4: Profit Structure and Cash Flow - The projected growth in net profit after deducting non-recurring items aligns closely with the overall net profit growth, suggesting that the profit increase is primarily driven by core business improvements rather than one-off items [9]. - The net cash flow from operating activities reached 468 million yuan in the first three quarters, significantly exceeding the profit growth rate [10][11]. Group 5: Structural Realization in a Normalized Environment - The performance forecast for 2025 reflects a structural realization, characterized by profit growth outpacing revenue growth and simultaneous improvement in net profit and cash flow [12]. - This indicates that the company has adapted to the normalized procurement environment and completed internal adjustments [12]. Group 6: Changing Growth Dynamics - The noteworthy aspect of the performance forecast is the change in growth dynamics, emphasizing profit elasticity, cash flow improvement, and gradual adaptation of the operational structure to the new environment [14].